Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunohistochemical analysis of tissue microarrays.
Simon R, Mirlacher M, Sauter G. Simon R, et al. Among authors: mirlacher m. Methods Mol Biol. 2010;664:113-26. doi: 10.1007/978-1-60761-806-5_12. Methods Mol Biol. 2010. PMID: 20690058
Tissue microarrays in cancer diagnosis.
Simon R, Mirlacher M, Sauter G. Simon R, et al. Among authors: mirlacher m. Expert Rev Mol Diagn. 2003 Jul;3(4):421-30. doi: 10.1586/14737159.3.4.421. Expert Rev Mol Diagn. 2003. PMID: 12877382 Review.
Tissue microarrays.
Simon R, Mirlacher M, Sauter G. Simon R, et al. Among authors: mirlacher m. Methods Mol Med. 2004;97:377-89. doi: 10.1385/1-59259-760-2:377. Methods Mol Med. 2004. PMID: 15064506 No abstract available.
Tissue microarrays.
Simon R, Mirlacher M, Sauter G. Simon R, et al. Among authors: mirlacher m. Methods Mol Med. 2005;114:257-68. doi: 10.1385/1-59259-923-0:257. Methods Mol Med. 2005. PMID: 16156109
Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.
Fleischmann A, Schlomm T, Huland H, Köllermann J, Simon P, Mirlacher M, Salomon G, Chun FH, Steuber T, Simon R, Sauter G, Graefen M, Erbersdobler A. Fleischmann A, et al. Among authors: mirlacher m. Clin Cancer Res. 2008 Dec 1;14(23):7838-42. doi: 10.1158/1078-0432.CCR-08-1432. Clin Cancer Res. 2008. PMID: 19047112
Tissue microarrays.
Dancau AM, Simon R, Mirlacher M, Sauter G. Dancau AM, et al. Among authors: mirlacher m. Methods Mol Biol. 2010;576:49-60. doi: 10.1007/978-1-59745-545-9_4. Methods Mol Biol. 2010. PMID: 19882257
Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.
Minner S, Jessen B, Stiedenroth L, Burandt E, Köllermann J, Mirlacher M, Erbersdobler A, Eichelberg C, Fisch M, Brümmendorf TH, Bokemeyer C, Simon R, Steuber T, Graefen M, Huland H, Sauter G, Schlomm T. Minner S, et al. Among authors: mirlacher m. Clin Cancer Res. 2010 Mar 1;16(5):1553-60. doi: 10.1158/1078-0432.CCR-09-2546. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179235
Recipient block TMA technique.
Mirlacher M, Simon R. Mirlacher M, et al. Methods Mol Biol. 2010;664:37-44. doi: 10.1007/978-1-60761-806-5_4. Methods Mol Biol. 2010. PMID: 20690050
58 results